Claritin Sales Grow For Schering-Plough Despite Zyrtec OTC Competition
This article was originally published in The Tan Sheet
Executive Summary
OTC Claritin sales advanced almost 10 percent in Schering-Plough's fiscal 2008 first quarter despite the "aggressive launch" of Johnson & Johnson's OTC Zyrtec, S-P says